![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, March 17, 2010 3:12:47 PM
I hope it is ok for me to state this here as I feel a little concerned on some of the things I have been hearing here lately. This posting is just my feelings over the last several days, so I hope it is ok for me to say it here.
We all have an opinion that may be different from another person.
We all have a feeling on what is best to do, and when we maybe should do things on this stock.
So long as we all say in a friendly and constructive way what we feel about this stock and why we feel that way can be a good thing. Not all of us will agree, which is ok, but it could give us insight into something we did not think about before.
I, for one, before felt this stock should be heading over $2 and stay there. This could possibly be looked at "pumping" the stock to make other people wanting to buy in and help me by keeping the price up and making more money; or that maybe I am trying to get it higher so I do not lose any money if I had bought higher then where is it currently standing when I posted the message.
I could also be saying I feel you should be selling the stock as I feel that it will be dropping soon. Some may look at this as "bashing" the stock. That I am either shorting or wanting to get it lower to buy in at a lower price and then hope it rises again.
We all have a feeling/thought on were this stock should be at, where it may be heading in price, as well as possible FDA approval/denial. I think so long as we keep our postings on this board as informative and always showing respect to the board and readers on this site, then we can help each other.
I would suggest if you are going to post a comment that reflects something you are stating as a fact, then please post a link to where you are seeing this to share with the reader. If it is a thought or feeling you have, then just let the reader know this is how you are feeling it may happen and why.
I have been feeling lately in reading that some strong feeling comments are being tossed around, and not always in a constructive friendly way. This is why I felt I needed to post something today as I have been feeling we are not respecting each other's thoughts on what may be happening with this stock.
My personal thought is if you do not agree with someone, and have very strong feelings about it that could be considered confrontational, then either please keep the emotional feeling out of a public reply back on the board, or if you want to have that emotion included in the reply then you may wish to reply back with a private post so it is kept away from the other readers on this board. I think most of us want to be constructive and informative here and wish to help others out, no matter what your feeling is on this stock and where it may take us in price per share.
I hope this posting in itself is not out of line on this board. I do not mean any bad feelings here nor am I trying to be confrontational. This posting is mostly just trying to express my thoughts only on how I am feeling lately here. I think there have been a lot of good thoughts and information has been shared here and look forward to reading more of them.
Larry
Recent HRTX News
- Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer • PR Newswire (US) • 09/03/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/06/2024 08:35:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:05:13 PM
- Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance • PR Newswire (US) • 08/06/2024 08:05:00 PM
- Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024 • PR Newswire (US) • 07/30/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/22/2024 01:54:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/22/2024 01:44:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/22/2024 01:32:57 PM
- Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System • PR Newswire (US) • 07/15/2024 12:00:00 PM
- Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") • PR Newswire (US) • 07/02/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:43:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 06:21:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 01:34:07 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/31/2024 03:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 12:05:11 PM
- Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN") • PR Newswire (US) • 05/29/2024 12:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 12:05:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 12:05:13 PM
- Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates • PR Newswire (US) • 05/07/2024 12:00:00 PM
- Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 • PR Newswire (US) • 04/24/2024 12:00:00 PM
- Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City • PR Newswire (US) • 04/11/2024 08:05:00 PM
- Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference • PR Newswire (US) • 03/28/2024 08:05:00 PM
- Biotech Finds Mid-Week Success Following Q4 Earnings Release • AllPennyStocks.com • 03/13/2024 08:25:00 PM
- Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates • PR Newswire (US) • 03/12/2024 08:05:00 PM
- Global Markets Await U.S. Inflation Report: Mixed Movements in Pre-Market Trading • IH Market News • 03/12/2024 11:22:57 AM
Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM
UC Asset announces plan of management stock buyback • UCASU • Sep 3, 2024 9:00 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM